Form 4: BioLife Solutions Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Todd Berard, Chief Marketing Officer of BioLife Solutions, sold 311 shares of common stock on October 30, 2024, to cover tax withholding obligations related to vesting restricted stock.
Summary
- On October 30, 2024, Todd Berard, the Chief Marketing Officer of BioLife Solutions Inc., sold 311 shares of the company's common stock.
- The sale was executed at a price of $23.15 per share.
- The transaction was conducted under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023.
- The purpose of the sale was to satisfy tax withholding obligations associated with the vesting of restricted stock.
- Following the transaction, Berard directly owns 107,847 shares of BioLife Solutions Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale for tax purposes, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This sale appears to be for tax purposes, which is a common reason for such transactions.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Date of adoption of Rule 10b5-1(c) trading plan |
| 10/30/2024 | Date of stock sale transaction |
| 11/01/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.